Gsa Capital Partners LLP Prothena Corp Public LTD CO Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Gsa Capital Partners LLP holds 210,555 shares of PRTA stock, worth $1.59 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
210,555Holding current value
$1.59 Million% of portfolio
0.09%Shares
12 transactions
Others Institutions Holding PRTA
# of Institutions
193Shares Held
45.1MCall Options Held
264KPut Options Held
56.4K-
Black Rock Inc. New York, NY3.86MShares$29.1 Million0.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX3.38MShares$25.4 Million3.14% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$16.9 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$16.4 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.27MShares$9.61 Million1.75% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $354M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...